Ricolinostat is not a highly selective HDAC6 inhibitor

被引:7
|
作者
Medard, Guillaume [1 ]
Sheltzer, Jason M. [2 ]
机构
[1] Natl & Kapodistrian Univ Athens, Dept Chem, Prote Core Facil, Athens, Greece
[2] Yale Univ, Sch Med, New Haven, CT 06520 USA
关键词
D O I
10.1038/s43018-023-00582-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:807 / 808
页数:2
相关论文
共 50 条
  • [31] Synthesis and Biological Investigation of Oxazole Hydroxamates as Highly Selective Histone Deacetylase 6 (HDAC6) Inhibitors
    Senger, Johanna
    Melesina, Jelena
    Marek, Martin
    Romier, Christophe
    Oehme, Ina
    Witt, Olaf
    Sippl, Wolfgang
    Jung, Manfred
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (04) : 1545 - 1555
  • [32] Design and synthesis of novel HDAC6 inhibitor dimer as HDAC6 degrader for cancer treatment by palladium catalysed dimerisation
    Lin, Ching
    Hsu, Jui-Ling
    Hsu, Yu-Tung
    Fan, Kuo-Chen
    Wu, Sian-Siou
    Lin, Miao-Hsia
    Guh, Jih-Hwa
    Yu, Chao-Wu
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2025, 40 (01)
  • [33] Discovery of a fluorescent probe with HDAC6 selective inhibition
    Zhang, Yingjie
    Yan, Jin
    Yao, Tso-Pang
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 141 : 596 - 602
  • [34] A highly HDAC6-selective inhibitor acts as a fluorescent probe
    Ho, Yi-Hsun
    Wang, Kuang-Jui
    Hung, Pei-Yun
    Cheng, Yi-Sheng
    Liu, Jia-Rong
    Fung, Sheang-Tze
    Liang, Pi-Hui
    Chern, Ji-Wang
    Yu, Chao-Wu
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2018, 16 (42) : 7820 - 7832
  • [35] Discovery of selective small-molecule HDAC6 inhibitor for overcoming proteasome inhibitor resistance in multiple myeloma
    Hideshima, Teru
    Qi, Jun
    Paranal, Ronald M.
    Tang, Weiping
    Greenberg, Edward
    West, Nathan
    Colling, Meaghan E.
    Estiu, Guillermina
    Mazitschek, Ralph
    Perry, Jennifer A.
    Ohguchi, Hiroto
    Cottini, Francesca
    Mimura, Naoya
    Goerguen, Guellue
    Tai, Yu-Tzu
    Richardson, Paul G.
    Carrasco, Ruben D.
    Wiest, Olaf
    Schreiber, Stuart L.
    Anderson, Kenneth C.
    Bradner, James E.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (46) : 13162 - 13167
  • [36] Reprogramming of myeloid and lymphoid cells in vitro by the HDAC6 selective inhibitor ITF3756
    Ripamonti, Chiara
    Stevenazzi, Andrea
    Vergani, Barbara
    Sandrone, Giovanni
    Marchini, Mattia
    Steinkuhler, Christian
    Fossati, Gianluca
    CANCER RESEARCH, 2022, 82 (12)
  • [37] Phase 1 Clinical Trial Of TN-301, A Highly Selective HDAC6 Inhibitor With Potential In HFPEF, Shows Target Engagement
    Bexon, Martin
    Argast, Gretchen
    Robertson, Laura
    Hoey, Timothy
    Vora, Jay
    Tingley, Whittemore
    Browns, Fran
    Schmelzer, Kara
    JOURNAL OF CARDIAC FAILURE, 2024, 30 (01) : 295 - 295
  • [38] Novel Single Inhibitor of HDAC6/8 and Dual Inhibitor of PI3K/HDAC6 as Potential Alternative Treatments for Prostate Cancer
    Guerra, Fabiana Selos
    Rodrigues, Daniel Alencar
    Fraga, Carlos Alberto Manssour
    Fernandes, Patricia Dias
    PHARMACEUTICALS, 2021, 14 (05)
  • [39] Aceroside VIII is a New Natural Selective HDAC6 Inhibitor that Synergistically Enhances the Anticancer Activity of HDAC Inhibitor in HT29 Cells
    Ryu, Hyun-Wook
    Lee, Dong-Hun
    Shin, Dong-Hee
    Kim, Seung Hyun
    Kwon, So Hee
    PLANTA MEDICA, 2015, 81 (03) : 222 - 227
  • [40] 选择性HDAC6抑制剂ricolinostat的合成新方法
    李永
    李毅
    李述敏
    王建塔
    樊玲玲
    中国医药工业杂志, 2018, 49 (01) : 45 - 48